USPTO serial 79383378
BIOSPRING
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 21, 2025
- Examiner
- FOSTER, ALEXANDRA M.
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIOSPRING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
BioSpring Gesellschaft für Biotechnologie mbH
DE
Other trademarks owned by BioSpring Gesellschaft für Biotechnologie mbH
BioSpring Gesellschaft für Biotechnologie mbH
DE
Other trademarks owned by BioSpring Gesellschaft für Biotechnologie mbH
BioSpring Gesellschaft für Biotechnologie mbH
DE
Other trademarks owned by BioSpring Gesellschaft für Biotechnologie mbH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julie A. Katz
Julie A. Katz Katz Group LLC1711 N. Hermitage Ave.Chicago, IL 60622United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Industrial chemicals; chemicals used in science; Nucleic acids for scientific purposes; Nucleotides for scientific and research use, namely, oligonucleotides | ACTIVE | — |
| 005 | Nucleic acid for medical diagnostic purposes; Oligonucleotides for medical diagnostic purposes; Oligonucleotides for pharmaceutical purposes; Pharmaceutical preparations for medical diagnostic purposes in the nature of diagnostic agents for medical use; chemical preparations for pharmaceutical purposes in the nature of diagnostic agents for medical use; Pharmaceutical preparations made of nucleic acids and nucleotides, in particular oligonucleotides, for pharmaceutical purposes | ACTIVE | — |
| 040 | Distilling of chemicals for others, namely, oligonucleotides; Custom manufacture of pharmaceuticals using oligonucleotides for third parties | ACTIVE | — |
| 042 | Scientific and technological services, and research and design in the field of nucleic acids, nucleotides and oligonucleotides; industrial analysis and industrial research of nucleic acids, nucleotides and oligonucleotides | ACTIVE | — |
| 044 | Analysis of nucleic acids and oligonucleotides for medical diagnostics and medical treatment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioSpring Gesellschaft für Biotechnologie mbH
- Other trademarks owned by BioSpring Gesellschaft für Biotechnologie mbH
- Other trademarks owned by BioSpring Gesellschaft für Biotechnologie mbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BIOSPRING
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 29, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 3, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 3, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| May 3, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 21, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 15, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 15, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 21, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 21, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 3, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 3, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 11, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 11, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 11, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 11, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 11, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 28, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 15, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 15, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 15, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 1, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 1, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 1, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 9, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 9, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 14, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 13, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 17, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 16, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |